HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
SHANGHAI GROWTH (00770) has a net asset value per share of $0.11 at the end of 2024.
14/01/2025
GMT Eight
SHANGHAI GROWTH (00770) announced that as of December 31, 2024, the unaudited net asset value per share of the company was $0.11.
Chalkis Health Industry (000972.SZ) plans to raise funds for the acquisition of related matters, trading suspended from January 14th.
HUTCHMED (00013) announced that VIKORY has received regular approval from the China National Medical Products Administration for the treatment of locally advanced or metastatic MET exon 14 skipping non-small cell lung cancer.
RECOMMEND
A-share subscription | Jiangnan New Materials (603124.SH) opens subscription, mainly engaged in the research and development of copper-based new materials.
5 min ago
Guotai Junan: Manus releases digital agent product, sparking excitement.
14 min ago
American Economy: Stagflation or Recession?
09/03/2025
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com